title: Irinotecan (CPT-11) in patients with advanced colorectal cancer previously treated with 5-fluorouracil-based chemotherapy.
authors.affiliation: AGII ANARGIRI Cancer Hospital, Athens, Greece. hecogoff@otenet.gr
authors.forename: G
authors.initials: G
authors.lastname: Aravantinos
authors.forename: D V
authors.initials: DV
authors.lastname: Skarlos
authors.forename: P
authors.initials: P
authors.lastname: Kosmidis
authors.forename: V
authors.initials: V
authors.lastname: Georgoulias
authors.forename: I
authors.initials: I
authors.lastname: Sgouros
authors.forename: D
authors.initials: D
authors.lastname: Bafaloukos
authors.forename: N
authors.initials: N
authors.lastname: Androulakis
authors.forename: S
authors.initials: S
authors.lastname: Florou
authors.forename: G
authors.initials: G
authors.lastname: Fountzilas
mesh_terms: D000328:Adult; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000633:toxicity; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D018572:Disease-Free Survival; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D000077146:Irinotecan; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D000077146:Irinotecan; D005472:Fluorouracil; D002166:Camptothecin